NLRP3 and hypertensive disorder: By activating the renin-angiotensin system and generating ROS in the paraventricular nucleus, direct inhibition of IL-1β, the primary proinflammatory cytokine in the NLRP3 inflammasome pathway, in addition to blocking NF-κB, also reduces hypertension (99).